INFLUENCE OF REGULATORY MEASURES AND MARKET POLICY FOR REIMBURSED MEDICINAL PRODUCTS ON THE VALUE, PAID WITH PUBLIC FUNDS IN BULGARIA IN 2015
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 6
Abstract
In Bulgaria large number of medicines yearly are included and excluded from Positive Drug List (PDL). It leads to different changes in the value per DDD paid with public funds (reference value) and utilization of medicines. The goal of the study is to analyze the main results from market policy of inclusion and exclusion of medicines in PDL as well as other factors leading to changes in reference value per DDD for all reimbursed medicines. The study is retrospective and observational analysis of Annex 1 and Annex 2 of Positive Drug List (PDL) in 2015. The changes in reference value per DDD, the rate of the decreasing or increasing of value were observed for all therapeutic groups in Annex 1 and Annex 2, where new medicines are included or excluded. We found that 109 new trademarks (belonging to 53 INNs), as well as 15 fixed dose combinations (belonging to 7 INN) in 2015 were included in Annex 1. 149 new trademarks, belonging to 67 INNs, were included in Annex 2, along with 16 fixed dose combinations (belonging to 7 INN). The number of excluded medicines is 60, belonging to 57 INNs from Annex 1, and 90 trademarks belonging to 85 INNs from Annex 2. On total the number of medicines in which the reference value is reduced is higher than medicines with the unchanged prices. The leading factor for decreasing the reference value in 2015 is a change of the price of the medicinal product within the group. It is mainly due to external reference comparison but also to generic and therapeutic competition. The next reason leading to decreasing the value is inclusion in PDL of generic medicines with lower prices.
Authors and Affiliations
Z. Mitkova
EFFECTIVENESS OF ANTIRETROVIRAL THERAPY IN CHILDREN LIVING WITH HIV/AIDS IN PLATEAU STATE SPECIALIST HOSPITAL, JOS, NIGERIA.
HIV in children is majorly due to vertical transmission that occurs during pregnancy, labour, delivery, or breastfeeding. About 3 million children were living with HIV in 2013, 650 get infected everyday, The aim of this...
STUDY OF SYMPTOMS, COMPLICATIONS AND THERAPEUTIC OPTIONS FOR THE CLINICAL MANAGEMENT OF UTERINE FIBROIDS
Background: Uterine fibroids are benign tumors that originate in the uterus (womb). These growths are typically not cancerous (benign). Uterine fibroids are the most common benign tumors in women of childbearing age. Obj...
ANTIBACTERIAL & ANTIFUNGAL POTENTIALITY OF RICINUS COMMUNIS & COLEUS FORSKOHLII ON SOME HUMAN PATHOGENIC MICROORGANISMS
The objective of the present study was to explore the antibacterial and antifungal activity of two plant extracts (Ricinus communis & Coleus forskohlii) against some selected pathogen (Staphylococcus aureus, Escherichia...
PHARMACOGNOSTICAL AND PHYTOCHEMICAL PROFILE OF VIDANGA (EMBELIA RIBES).SEEDS - A REVIEW
Vidanga (Embelia ribes Burm F.) belong to the family Myrsinaceae. Vidanga is a medicinal plant uses in Ayurveda system for medicine for the treatment of various ailment sines vedic to modern period. It is preferably and...
IMPLEMENTATION OF A COMMUNITY PILOT CARDIOVASCULAR HEALTH PROGRAM
Mexico is currently suffering from serious problems of obesity based on data from the national survey of health - ENSANUT – 2016[1], shows that 70% of adults aged 30-60 suffer from overweight or obesity, seven in 10 adul...